These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 35718078
21. Topography of Simulated Intestinal Equilibrium Solubility. Dunn C, Perrier J, Khadra I, Wilson CG, Halbert GW. Mol Pharm; 2019 May 06; 16(5):1890-1905. PubMed ID: 30848917 [Abstract] [Full Text] [Related]
22. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors. Madsen CM, Boyd B, Rades T, Müllertz A. Eur J Pharm Sci; 2016 Aug 25; 91():31-9. PubMed ID: 27260089 [Abstract] [Full Text] [Related]
23. An In-Depth View into Human Intestinal Fluid Colloids: Intersubject Variability in Relation to Composition. Riethorst D, Baatsen P, Remijn C, Mitra A, Tack J, Brouwers J, Augustijns P. Mol Pharm; 2016 Oct 03; 13(10):3484-3493. PubMed ID: 27576295 [Abstract] [Full Text] [Related]
24. Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs. Prasad D, Gu CH, Kuldipkumar A. Pharm Dev Technol; 2016 Oct 03; 21(4):511-7. PubMed ID: 25703029 [Abstract] [Full Text] [Related]
25. Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine. Holmstock N, De Bruyn T, Bevernage J, Annaert P, Mols R, Tack J, Augustijns P. Eur J Pharm Sci; 2013 Apr 11; 49(1):27-32. PubMed ID: 23402972 [Abstract] [Full Text] [Related]
26. Human intestinal fluid factors affecting intestinal drug permeation in vitro. Riethorst D, Brouwers J, Motmans J, Augustijns P. Eur J Pharm Sci; 2018 Aug 30; 121():338-346. PubMed ID: 29902511 [Abstract] [Full Text] [Related]
27. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption. Augustijns P, Wuyts B, Hens B, Annaert P, Butler J, Brouwers J. Eur J Pharm Sci; 2014 Jun 16; 57():322-32. PubMed ID: 23994640 [Abstract] [Full Text] [Related]
28. Solubility profiling of HIV protease inhibitors in human intestinal fluids. Wuyts B, Brouwers J, Mols R, Tack J, Annaert P, Augustijns P. J Pharm Sci; 2013 Oct 16; 102(10):3800-7. PubMed ID: 23939880 [Abstract] [Full Text] [Related]
29. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development. Khoshakhlagh P, Johnson R, Langguth P, Nawroth T, Schmueser L, Hellmann N, Decker H, Szekely NK. J Pharm Sci; 2015 Jul 16; 104(7):2213-24. PubMed ID: 25964103 [Abstract] [Full Text] [Related]
30. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling. Jones HM, Parrott N, Ohlenbusch G, Lavé T. Clin Pharmacokinet; 2006 Jul 16; 45(12):1213-26. PubMed ID: 17112297 [Abstract] [Full Text] [Related]
31. Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states. Litou C, Patel N, Turner DB, Kostewicz E, Kuentz M, Box KJ, Dressman J. Eur J Pharm Sci; 2019 Oct 01; 138():105031. PubMed ID: 31386891 [Abstract] [Full Text] [Related]
32. Evaluation of food effect on the oral absorption of clarithromycin from immediate release tablet using physiological modelling. Radwan A, Jayyousi R, Shraim N, Zaid AN. Biopharm Drug Dispos; 2019 Apr 01; 40(3-4):121-134. PubMed ID: 30891805 [Abstract] [Full Text] [Related]
33. Human and simulated intestinal fluids as solvent systems to explore food effects on intestinal solubility and permeability. Stappaerts J, Wuyts B, Tack J, Annaert P, Augustijns P. Eur J Pharm Sci; 2014 Oct 15; 63():178-86. PubMed ID: 25063035 [Abstract] [Full Text] [Related]
34. Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability. Wuyts B, Riethorst D, Brouwers J, Tack J, Annaert P, Augustijns P. Int J Pharm; 2015 Jan 30; 478(2):736-44. PubMed ID: 25510602 [Abstract] [Full Text] [Related]
35. Characterization of neonatal and infant enterostomy fluids - part II: Drug solubility. de Waal T, Brouwers J, Rayyan M, Stillhart C, Vinarova L, Vinarov Z, Augustijns P. Int J Pharm; 2023 Jul 25; 642():123141. PubMed ID: 37321462 [Abstract] [Full Text] [Related]
36. Impact of phospholipid digests and bile acid pool variations on the crystallization of atazanavir from supersaturated solutions. Enright EF, Joyce SA, Gahan CGM, Taylor LS. Eur J Pharm Biopharm; 2020 Aug 25; 153():68-83. PubMed ID: 32473291 [Abstract] [Full Text] [Related]
37. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans. Shono Y, Jantratid E, Kesisoglou F, Reppas C, Dressman JB. Eur J Pharm Biopharm; 2010 Sep 25; 76(1):95-104. PubMed ID: 20576487 [Abstract] [Full Text] [Related]
38. Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid. Indulkar AS, Gao Y, Raina SA, Zhang GGZ, Taylor LS. Pharm Res; 2018 Jun 18; 35(8):158. PubMed ID: 29916053 [Abstract] [Full Text] [Related]
39. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability. Falavigna M, Klitgaard M, Steene E, Flaten GE. Eur J Pharm Sci; 2019 Apr 30; 132():44-54. PubMed ID: 30822502 [Abstract] [Full Text] [Related]
40. Evaluating Solubility of Celecoxib in Age-Appropriate Fasted- and Fed-State Gastric and Intestinal Biorelevant Media Representative of Adult and Pediatric Patients: Implications on Future Pediatric Biopharmaceutical Classification System. Shawahna R, Zyoud A, Haj-Yahia A, Taya R. AAPS PharmSciTech; 2021 Mar 01; 22(3):84. PubMed ID: 33649887 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]